SelikoffIJGreenbergM.“A landmark case in asbestosis.”JAMA1991; 265: 898–901.
2.
HardellLSandstromA.“Case-control study: Soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols.”Br J Cancer1979; 39: 711–717.
3.
ErikssonMHardellLBergNOMollerTAxelsonO.“Soft tissue sarcoma and exposure to chemical substances: A case referent study.”Br J Ind Med1981; 38: 27–33.
4.
HardellLErikssonMLennerPLundgrenE.“Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids.”Br J Cancer1981; 43: 169–176.
5.
LilienfeldDEGalloMA. “2,4-D, 2,4,5-T, and 2,3,7,8-TCDD: An overview”Epidemiol Rev1989; 11: 28–58.
6.
KocibaRKeyesDBeyerJ“Results of two-year chronic toxicity and oncogenic study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats.”Toxicol Appl Pharmacol1978; 46: 279–303.
7.
PitotHCGoldsworthyTCampbellHAPolandA.“Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.”Cancer Research1980; 40: 3616–3620.
8.
National Toxicology Program, National Cancer Institute: NIH bioassay of a mixture of 1,2,3,6,7,8- and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxins for carcinogenicity (gavage study). Natl Toxicol Program Tech Rep Ser No. 198, DHHS Publ No. (NIH)80-198. Research Triangle Park, NC: Natl Toxicol Program1980.
9.
National Toxicology Program, National Cancer Institute: Toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures in B6C3F1 mice. Natl Toxicol Program Tech Rep Ser No. 349, DHHS Publ No. (NIH)89-2804. Research Triangle Park, NC: Natl Toxicol Program, 1989.
10.
IARC“Monographs on the Evaluation of Carcinogenic Risks to Humans.”Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, Volumes 1 to 42, Supplement 7. Lyon, France1987, pp 350–354.
11.
HuffJESalmonAGHooperNKZeiseL.“Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins.”Cell Biol Toxicol1991; 7: 6794.
12.
HardellLErikssonM.“The association between soft-tissue sarcomas and exposure to phenoxyacetic acids: A new case referent study.”Cancer1988; 62: 652–656
13.
ErikssonMHardellLAdamiHO. “Exposure to dioxins as a risk factor for soft-tissue sarcoma: A population-based case control study.”J Natl Cancer Inst1990; 82: 486–90.
14.
PerssonBDahlanderAMFredrikssonMBrageNoorlind HOhlssonCGAxelsonO.“Malignant lymphomas and occupational exposures.”Br J Ind Med1989; 46: 516–520.
15.
PerssonBFredrikssonMOlsenKBoerydBAxelsonO.“Some occupational exposures as risk factors for malignant lymphomas.”Cancer1993; 72: 1773–1778.
16.
WingrenGFredrikssonMBrageNoorlind HNordenskjoldBAxelsonO.“Soft tissue sarcoma and occupational exposures.”Cancer1990; 66: 806–811.
17.
HoarSKBlairAHolmesFF“Agricultural herbicide use and risk of lymphomas and soft-tissue sarcoma.”JAMA1986; 256: 1141–1147.
18.
Hoar-ZahmSWeisenburgerDDBabbittPA“A case control study of non-Hodgkin's lymphoma and the herbicide 2,4, dichlorophenoxyacetic acid (2,4-D) in Eastern Nebraska.”Epidemiology1990; 1: 349–356.
19.
FingerhutMAHalperinWEMarlowDA“Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.”N Engl J Med1991; 324: 212–218.
20.
SaracciRKogevinasMBertazziPA“Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols.”Lancet1991; 338: 1027–1032.
21.
HardellLErikssonMAxelsonOFredrikssonM.“Dioxin and mortality from cancer.”N Engl J Med1991; 324: 1810.
22.
ManzABergerJDwyerJHFlesch-JanysDNagelSWaltsgottH.“Cancer mortality among workers in chemical plant contaminated with dioxin.”Lancet1991; 338: 959–964.
23.
ZoberAMessererPHuberP.“Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident.”Int Arch Occup Environ Health1990; 62: 139–157.
24.
AxelsonOSundellL.“Herbicide exposure, mortality and tumor incidence. An epidemiological investigation on Swedish railroad workers.”Work Environ Hlth1974; 11: 21–28.
25.
AxelsonOSundellLAnderssonKEdlingCHogstedtCKlingH.“Herbicide exposure and tumor mortality; an updated epidemiological investigation on Swedish railroad workers.”Scand J Work Environ Hlth1980; 6: 73–79.
26.
HogstedtCWesterlundB.“Cohort studies of cause of death of forest workers with and without exposure to phenoxy acid preparations” (in Swedish). Lakartidningen1980; 77: 1828–1831.
27.
BertazziPAPesatoriACConsonniDTironiALandiMTZochettiC.“Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-paradioxin.”Epidemiology1993; 4: 398–406.
28.
Veterans and Agent Orange. Health Effects of Herbicides Used in Vietnam. National Academy Press. Washington, D.C.1993.
29.
ColeP.Direct testimony before the Environmental Protection Agency of the United States of America. Washington, DC: Exhibit 860, 1980, pp 2–24.
30.
Royal Commission on the Use and Effects of Chemical Agents on Australian Personnel in Vietnam. “Final Report,”Vols 1–9. Canberra: Australian Government Publishing Service1985.
31.
AxelsonO (ed). “Rebuttals of the Final Report on Cancer by the Royal Commission on the Use and Effects of Chemical Agents on Australian Personnel in Vietnam.” Report No. Liu-YMED-R-6. Linkoping, Sweden: University of Linkoping1986.
32.
AxelsonOHardellL.“Storm in a cup of 2, 4, 5-T.”Med J. Aust1986; 144; 612–613.
33.
HardellLAxelsonO.“Storm in a cup of 2, 4, 5-T.”Med J Aust1986; 145: 299.
34.
HardellLAxelsonO.“The boring story of Agent Orange and the Australian Royal Commission.”Med J Aust1989; 150: 602.
35.
Monsanto Australia Limited. “Axelson and Hardell — The Odd Men Out.” Submission to the Royal Commission on the Use and Effects of Chemical Agents on Australian Personnel in Vietnam. Exhibit 1881. 1985, pp 64–69, 146–237.
36.
DollR.Letter to The Hon. Mr Justice Philip Evatt, Australian Royal Commission on the Use and Effects of Chemical Agents on Australian Personnel in Vietnam. December 4, 1985.
37.
YoungALReggianiGM (eds). Agent Orange and Its Associated Dioxin: Assessment of a Controversy. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division)1988.
38.
YoungALReggianiGM. Re: Letter to the editor on “Agent Orange and its associated dioxins: Assessment of a Controversy”. Am J Ind Med1991; 19: 399–402.
39.
DollR.“Are we winning the fight against cancer? An epidemiological assessment.”Eur J Cancer1990; 26: 500–508.
40.
Comments by Department of Veterans' Affairs, Attachment C, Woden, Australia, May 19, 1988.
41.
JohnsonES. “Human exposure to 2,3,7,8-TCDD and risk of cancer.”CRC Critical Reviews In Toxicology1992; 21: 451–464.
42.
YoungALKangHKShepardBM. “Chlorinated dioxins as herbicide contaminants.”Environ Sci Technol1983; 17(ll): 530–540.
43.
ReggianiG.“Localized contamination with TCDD — Seveso, Missouri and other areas.” In KimbroughR (ed): Halogenated Biphenyls, Terphenyls, Naphtalenes, Dibenzodioxins and Related Products. Amsterdam: Elsevier/North-Holland Biomedical Press. 1980, pp 303–371.
44.
HardellL.“Serious errors in new volume on Agent Orange and dioxin.”Am J Ind Med1990; 17: 261–267.
45.
HardellL.“Re: Agent Orange controversy: A response.”Am J Ind Med1991; 19: 403–405.
46.
ColtonT.“Herbicide exposure and cancer” (editorial). JAMA1986; 256: 1176–1178.
47.
HardellLErikssonM.“The association between cancer mortality and dioxin exposure: A comment on the hazard of repetition of epidemiological misinterpretation.”Am J Ind Med1991; 19: 547–549.
48.
Kemner, et al v. Monsanto Company, Civil No. 80-L-970, Circuit Crt., St. Clair County, Illinois. Report of Proceedings. Testimony of Dr. George Roush, 1985, July 8, pp 1–147, July 9, pp 1–137.
49.
ZackJAGaffeyWR. “A mortality study of workers employed at the Monsanto company plant in Nitro, West Virginia.”Env Sci Res1983; 26: 575–591.
50.
SuskindRRHertzbergVS. “Human health effects of 2,4,5-T and its toxic contaminants.”JAMA1984; 251: 2372–2380.
51.
Kemner, et al v. Monsanto Company, Civil No. 80-L-970, Circuit Crt., St. Clair County, Illinois. Report of Proceedings. Testimony of Dr. George Roush, 1985, July 22, pp 1–76.
52.
WattersonA.“Chemical hazards and public confidence.”Lancet1993; 342: 131–132.